Hjertemagnyl

DRUG3 trials

Sponsors

Aarhus University Hospital, Odense University Hospital

Conditions

Acute coronary syndromesIschemic StrokeIschemic heart disease/Chronic coronary syndrome (Myocardial infarctioncoronary artery bypass grafting)percutaneous coronary intervention

Phase 2

The safety and efficacy of acute subcutaneous administration of semaglutide in non-diabetic patients with acute ischemic stroke: a multicentre, phase 2, prospective, randomized, open-label, blinded endpoint trial (ASSET)

RecruitingCTIS2022-501072-25-02

Aarhus University HospitalIschemic Stroke

Start: 2023-04-12Target: 380Updated: 2023-06-20

Phase 3

Randomized comparison of short versus 12 months prasugrel plus aspirin in patients with acute coronary syndromes treated with percutaneous coronary intervention and everolimus-eluting stents

CompletedCTIS2024-515236-69-00

Odense University HospitalAcute coronary syndromes

Start: 2024-12-13End: 2025-10-17Target: 3150Updated: 2024-08-23

The RELEASE Trial: Reconsidering Long-Term Aspirin in the Elderly in Secondary Prevention of Cardiovascular Disease

Not yet recruitingCTIS2026-525442-30-00

Odense University Hospitalcoronary artery bypass grafting), Ischemic heart disease/Chronic coronary syndrome (Myocardial infarction, percutaneous coronary intervention

Target: 7000Updated: 2026-07-06